LAUSR

Tamonwan Chamroensakchai, Wasin Manuprasert, Pongpratch Puapatanakul, Thunvarat Saejew, Asada Leelahavanichkul, Tanittha Chatsuwan, Guttiga Halue, Pichet Lorvinitnun, Kittisak Tangjittrong, Krit Pongpirul, Kriang Tungsanga, Somchai Eiam-Ong, David W. Johnson and Talerngsak Kanjanabuch; on behalf of the Thailand PD Outcomes and Practice Patterns Study (PDOPPS) Steering Committee Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Center of Excellence in Kidney Metabolic Disorders, Chulalongkorn University, Bangkok, Thailand; Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; CAPD Excellence Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Department of Medicine, Phayao Hospital, Phayao, Thailand; Department of Medicine, Sunpasitthiprasong Hospital, Ubon Ratchathani, Thailand; Division of Nephrology, Department of Internal Medicine, Pranangklao Hospital, Nonthaburi, Thailand; Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Queensland, Australia; and Centre for Kidney Disease Research, Translational Research Institute, Brisbane, Queensland, Australia